Vir Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	86.18	1,616	1,095	76.37	8.09	10.67	2.71
Revenue Growth (YoY)	-94.67%	47.51%	1334.39%	843.86%	-24.16%	293.94%	-
Cost of Revenue	2.77	146.32	65.87	0	0	0	0
Gross Profit	83.42	1,469	1,030	76.37	8.09	10.67	2.71
Selling, General & Admin	178.05	161.76	160.79	70.94	37.6	29.13	21.69
Research & Development	589.67	474.65	448.01	302.41	148.47	100.23	62.51
Operating Expenses	767.72	636.41	608.8	373.35	186.07	129.36	84.21
Operating Income	-684.31	833.07	420.75	-296.98	-177.98	-118.69	-81.5
Other Expense / Income	-56.17	78.79	-129.05	1.63	-3.45	-2.33	-0.72
Pretax Income	-628.14	754.28	549.8	-298.61	-174.53	-116.36	-80.78
Income Tax	-13.08	238.44	21.22	0.05	0.15	-0.48	-10.92
Net Income	-615.06	515.84	528.58	-298.67	-174.68	-115.88	-69.85
Net Income Growth	-	-2.41%	-	-	-	-	-
Shares Outstanding (Basic)	134	133	130	119	30	8	2
Shares Outstanding (Diluted)	134	135	133	119	30	8	2
Shares Change	-0.50%	1.03%	11.98%	292.62%	295.88%	256.20%	-
EPS (Basic)	-4.59	3.89	4.07	-2.51	-5.76	-15.12	-32.45
EPS (Diluted)	-4.59	3.83	3.96	-2.51	-5.76	-15.12	-32.45
EPS Growth	-	-3.28%	-	-	-	-	-
Free Cash Flow	-800.36	1,595	-69.41	-197.49	-138.57	-102.26	-69.12
Free Cash Flow Per Share	-5.97	12.03	-0.53	-1.66	-4.57	-13.34	-32.12
Gross Margin	96.79%	90.94%	93.99%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-794.04%	51.56%	38.41%	-388.88%	-2199.72%	-1112.60%	-3009.49%
Profit Margin	-713.69%	31.92%	48.25%	-391.09%	-2158.98%	-1086.28%	-2579.47%
Free Cash Flow Margin	-928.71%	98.73%	-6.34%	-258.60%	-1712.67%	-958.60%	-2552.55%
Effective Tax Rate	-	31.61%	3.86%	-	-	-	-
EBITDA	-601.03	769.77	561.79	-289.8	-170.01	-113.61	-80.34
EBITDA Margin	-697.41%	47.64%	51.29%	-379.48%	-2101.25%	-1064.94%	-2966.91%
Depreciation & Amortization	27.11	15.49	11.98	8.81	4.52	2.76	0.43
EBIT	-628.14	754.28	549.8	-298.61	-174.53	-116.36	-80.78
EBIT Margin	-728.87%	46.68%	50.19%	-391.02%	-2157.08%	-1090.78%	-2982.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).